Exhibit A: Case special edition #1 | — The Receipt on the Kitchen Table
The receipt on the kitchen table lay beneath a glass of water as if it might otherwise blow away. David Mercer had placed it there an hour earlier when he came home from the pharmacy, and since then he had looked at it often enough that the number no longer felt like a price. It felt like a verdict.
The paper was thin and glossy, curled at one corner where the cashier must have torn it too quickly from the register spool. Across the top was the pharmacy logo. Beneath that, the date. Beneath that, the itemized list of things a twelve-year-old boy needed to stay alive for thirty more days.
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
Three insulin pens. Testing supplies. Alcohol swabs.
At the bottom, in dark, indifferent ink:
$1,842.16
David sat at the table in his work shirt with the collar open and the sleeves still rolled halfway up his forearms. He had come straight from the machine shop without changing, carrying the pharmacy bag in one hand and a carton of eggs in the other, because life had a way of requiring groceries and catastrophe in the same trip.
The apartment was warm in the tired way old buildings got warm in February. The radiator beneath the kitchen window gave off a metallic heat that smelled faintly of dust and old paint. On the sill above it sat a wilted basil plant Eli kept insisting could be saved. Outside, a crust of dirty snow clung to the curb and the parking lot reflected the orange streetlights in flat streaks across the ice.
Across from him, Eli Mercer leaned over a spiral notebook, chewing lightly on the side of his pencil while he worked through a page of fractions. His dark hair had grown a little too long over the ears again. David had noticed it that morning while Eli was tying his shoes for school and made a mental note to take him for a haircut on Saturday if there was enough left after rent.
A small continuous glucose monitor was clipped to the waistband of Eli’s sweatpants. Every few minutes it pulsed a soft green light, quiet as a watchful eye.
“Dad,” Eli said, not looking up from the notebook, “is seven-eighths bigger than three-quarters?”
David stared at the receipt another moment before lifting his head.
“Yeah. A little.”
“How little?”
David took a breath, grateful for the question because it involved a kind of arithmetic that still behaved honestly.
“Think of it this way. Three-quarters is six-eighths. So seven-eighths is bigger by one-eighth.”
Eli nodded, satisfied, and wrote something down in his notebook with great seriousness.
Twelve years old, David thought. Still young enough to ask math questions across a kitchen table. Old enough to know the names of his insulin brands, what foods hit his blood sugar too hard, and how to read the expression on his father’s face when money had gone bad.
The pharmacy bag sat on the counter near the sink. Inside were the insulin pens in their white cartons, cold packs already softening around them. David had meant to put everything away immediately, but the receipt had stopped him. He’d set the glass of water on top of it and stood there for a while with one hand on the counter, staring at the number until the room around him seemed to recede.
It was not the first punishing receipt. It was only the newest.
When Eli was eight, he had dropped twelve pounds in a month and started waking three times a night to use the bathroom. David told himself it was a growth spurt until the school nurse called one afternoon and said Eli looked pale and unfocused and could someone please pick him up. Two hours later they were in the emergency room with fluorescent lights over everything and a resident speaking gently but too quickly about blood sugar levels, ketones, and something called diabetic ketoacidosis.
David still remembered the first night in the hospital with a physical clarity that embarrassed him. The hard vinyl chair beside the bed. The stale smell of coffee from the family waiting area. The blue blanket pulled to Eli’s chest. The IV taped to his hand. The doctor explaining that Type 1 diabetes was not caused by anything they did wrong and could not be reversed and would now require insulin every single day.
Eli had listened longer than most children would have. Then he looked up from the bed and asked, “Does this mean I can’t eat birthday cake anymore?”
The doctor smiled before answering.
“You can still have birthday cake.”
Eli had thought about that carefully and nodded, as if terms had been reached.
Since then the years had arranged themselves around numbers. Carbohydrates. Units. Correction factors. Insurance deductibles. Co-pays. Refill dates. David learned to carry granola bars in his coat pocket and juice boxes in the car. He learned the subtle difference in Eli’s face when his blood sugar was low and dropping fast. He learned how quickly a good month could turn into a bad one if the deductible reset or the pharmacy changed suppliers or a letter arrived saying the formulary had been updated and their old insulin was now “non-preferred,” as if a body could be persuaded to change its chemistry by bureaucratic tone.
He also learned that every conversation about insulin prices ended the same way: with someone somewhere describing the situation as unfortunate.
On the refrigerator, held by a magnet shaped like a baseball glove, was a school flyer for the state science museum’s summer astronomy weekend. Eli had seen it three weeks earlier and fallen in love immediately because the flyer showed a boy at a telescope with Saturn hanging in the black sky behind him like something painted there just for him.
“You think we could go?” he had asked.
David said they’d see.
It was what he said whenever the answer depended on numbers he had not yet faced honestly.
Now the flyer lifted slightly in the radiator heat, tapping against the refrigerator door.
Eli put down the pencil and rubbed his eyes.
“You got the insulin?”
“Yeah.”
“All of it?”
“All of it.”
Eli nodded once, and David saw the relief pass through him before the boy looked back down at the notebook. It was not dramatic. That was the part David found hardest. Children adapted to fear with a speed that broke something in you. Eli no longer asked whether they would be able to get the medicine. He only asked if David had gotten it.
The answer itself had become the comfort.
David reached for the receipt and slid it out from under the glass. The paper made a dry whisper against the wood grain of the table. There were nicks and scratches all along that tabletop from the years before Eli was diagnosed, when homework had meant crayons and model airplanes and things a child could outgrow.
Now every surface in the apartment held evidence of management. Lancets in a drawer. Alcohol wipes in a basket by the microwave. Emergency glucose tabs in the bathroom medicine cabinet. Half a dozen sticky notes with numbers written on them and crossed out. Living had become a small private clinic no one got paid to run.
“Dad?”
David looked up.
Eli had turned the notebook around and was pointing at a problem involving equivalent fractions.
“If six-eighths is the same as three-quarters, then why do they write it different?”
David almost answered automatically, but something in the question caught him. He looked at the page. Then at the receipt in his hand.
“Because sometimes,” he said, “people use different numbers for the same thing.”
Eli frowned. “Why?”
David let out a breath through his nose and managed a small smile.
“To make math homework harder.”
Eli accepted that with the weary patience children reserve for adult nonsense and went back to work.
On the television in the living room, the evening news murmured under a pharmaceutical ad. Smiling grandparents walked along a beach while a voice listed side effects in a tone so warm it might have been describing weather. David stood, crossed the room, and turned up the volume with the remote.
A Capitol backdrop appeared on screen behind the anchor.
“…expected tomorrow, the Senate will take up the Affordable Insulin Access Act, legislation that would cap monthly insulin costs for patients nationwide…”
David stood very still.
The bill had moved further than most people expected. For months it had lived in that half-world where major stories go to die politely, discussed on panels, praised in speeches, and delayed in committee rooms where the fluorescent lights never made the news. But over the last several weeks something had shifted. Too many parents had shown up. Too many stories had gotten loose. Too many people had started asking why a century-old drug had become a luxury item.
Two weekends earlier David had taken the bus to Washington with a church group and three other parents from his county. He spent six hours standing in the cold with a paper cup of bad coffee and a photograph of Eli printed at the copy shop down the street. In the photo, Eli was eight years old in a hospital bed, smiling weakly into the camera with the first insulin pump clipped to his gown.
A staffer from one senator’s office had come out to speak with them. She wore a navy coat and held a legal pad against her chest.
“The senator is committed to affordable access,” she said.
David remembered the phrase because it sounded polished enough to have been used many times before. Still, he had believed something that day. Not fully. Not foolishly. But enough.
Enough to imagine a month where the refill did not arrive like a threat.
Enough to imagine the museum flyer coming down from the refrigerator and becoming a plan instead of a maybe.
Enough to imagine opening a pharmacy receipt and not needing a minute before reading the bottom line.
The segment ended. David lowered the volume and went back to the kitchen.
Eli was staring at the science museum flyer now.
“If the bill passes,” he said, “does that mean mine will only cost thirty-five dollars?”
David sat down slowly.
“That’s what they’re saying.”
“For all of it?”
“For the month, yeah.”
Eli looked at him with open amazement.
“That’s less than my field trip cost.”
David laughed once, softly.
“Yeah.”
Eli grinned and looked toward the fridge again, already building a future from the number.
“Then we can do the astronomy weekend.”
David should have said maybe. He should have stayed disciplined. But the room was warm, and the insulin was in the refrigerator, and for the first time in months the possibility of relief felt close enough to touch.
“Yeah,” he said. “Maybe we can.”
Eli’s whole face changed. It wasn’t just happiness. It was expansion. The immediate widening of a child’s world when something moves from dream to possible.
“They let you stay overnight,” he said, excitement quickening his voice. “And they have that giant telescope on the roof. And there’s that thing where you can hold the meteorite.”
“I saw.”
“And maybe this summer we could go to the real observatory too. The one upstate.”
“Let’s start with one planetarium, astronaut.”
Eli smiled so hard it nearly undid David.
Then the glucose monitor buzzed.
Not loud. Just the short vibration meaning the reading had drifted and needed attention.
Eli held out his hand automatically.
David passed him the finger-stick kit from the table. The boy pricked his finger, squeezed out a small bead of blood, and waited while the meter counted down.
These were the moments that stripped all rhetoric from life. No speeches. No politics. Just blood, numbers, plastic, and a child trying to stay within range.
Eli glanced at the result and nodded.
“I’m okay.”
He cleaned his finger with a tissue and sat back down.
David folded the receipt once, then again, then laid it flat beneath the glass of water as if putting it back under pressure might keep the hope in the room from leaking out.
His phone vibrated on the table.
He expected a work text or a pharmacy follow-up.
Instead it was a news alert.
He opened it.
The headline was short enough to absorb in a single breath.
SENATE LEADERSHIP PULLS INSULIN PRICE CAP BILL FROM FLOOR SCHEDULE AFTER INDUSTRY OBJECTIONS
David did not move.
He opened the article.
A staff-written update explained that the legislation had been removed from the next day’s voting calendar after late negotiations broke down among party leadership, key donors, and pharmaceutical representatives. Lawmakers described the bill as “still under discussion.” Several senators expressed disappointment. One promised to keep fighting. Another called for more study.
No vote.
No names that mattered.
No number attached to the thing that had just been taken away from his kitchen.
Across the table, Eli was still talking, softly now, almost to himself, about the astronomy weekend. Which night would be best for seeing Saturn. Whether telescopes could show the rings clearly or only as a blur. Whether the museum gift shop might sell little glow-in-the-dark star charts.
David turned the screen dark and set the phone face down.
The radiator hissed. A car door slammed outside. Somewhere in another apartment someone laughed at something on television.
On the kitchen table, beneath the glass of water, the receipt stayed where it was.
$1,842.16
Eli looked up.
“What?”
David realized the boy had asked him a question he had not heard.
“Nothing,” David said.
Become a member of the Dossier.
Support my writing.
The Question | The Receipt on the Kitchen Table
David Mercer has done nothing wrong.
His son has a disease that has been treatable for a century. The medicine exists, the prescription is valid, and the pharmacy has already filled it.
Yet the price remains $1,842 for thirty days.
Congress was scheduled to vote on legislation that would cap the cost of insulin nationwide.
The vote will not happen.
So how does a political system justify allowing a life-sustaining drug to remain financially out of reach when the solution had already reached the Senate floor?
Autopsy | The Receipt on the Kitchen Table
The insulin bill did not disappear because a vote failed.
It disappeared because the vote never happened.
In Congress, most legislation dies quietly long before the public sees a roll call. Bills are scheduled, delayed, amended, referred back to committee, or simply removed from the calendar by leadership. These decisions rarely attract attention because they occur inside procedural negotiations that shape what lawmakers will ultimately be allowed to vote on.
For pharmaceutical legislation, those negotiations take place in an environment shaped heavily by lobbying and campaign finance.
The pharmaceutical industry is consistently among the largest lobbying forces in Washington. Major manufacturers and their trade organizations maintain permanent lobbying offices near Capitol Hill staffed by former congressional aides, policy specialists, and legal analysts who monitor legislation affecting drug pricing, patent protections, and insurance reimbursement structures.
These groups do more than offer policy advice.
They also participate in the campaign finance system that now surrounds federal elections. Following the Supreme Court’s decision in Citizens United v. Federal Election Commission, corporations and industry organizations gained the ability to spend unlimited amounts of money through independent political committees supporting candidates whose positions align with their interests.
These committees—often called Super PACs—operate separately from campaigns but can raise and spend vast sums promoting or opposing candidates during elections.
As a result, legislators who influence pharmaceutical policy often find themselves operating inside a political ecosystem heavily financed by the same industry their legislation might regulate.
The relationship is not always explicit.
A pharmaceutical company rarely needs to call a senator and demand a bill be stopped. Lobbyists instead present economic arguments about research investment, innovation incentives, and the potential consequences of price controls. Political committees signal support during election cycles. Campaigns depend on those signals to remain competitive.
Within that environment, legislative scheduling becomes one of the most powerful tools available.
A bill that reaches the Senate floor must force every senator to take a public position. A bill that never reaches the floor avoids that confrontation entirely. Leadership can remove it from the calendar, delay it for further negotiation, or return it to committee for additional review.
From the outside, the result looks like delay.
Inside the system, the process is understood as negotiation.
Industry representatives argue that strict price caps could reduce research investment or disrupt pharmaceutical markets. Lawmakers weigh those arguments against the political consequences of alienating a powerful industry that contributes heavily to election financing across both parties.
The legislation becomes part of a broader calculation.
Some bills survive that calculation.
Others are quietly withdrawn before a vote forces the issue into public view.
The Affordable Insulin Access Act had reached the point where a vote was possible. Negotiations continued behind the scenes among senators, committee staff, and industry representatives.
Then the bill disappeared from the schedule.
No senator had to vote against it.
No public debate occurred.
The legislation simply stopped moving.
Reader’s Verdict | The Receipt on the Kitchen Table
No senator stood on the floor and argued that insulin should cost $1,842 a month.
No one publicly defended the price.
The vote simply never happened.
The bill disappeared from the calendar after negotiations with an industry that spends hundreds of millions of dollars influencing the political environment in which those same senators must survive.
The system followed its rules.
Lobbyists represented their clients.
Political committees funded campaigns.
Lawmakers protected the alliances that keep them electable.
Nothing illegal occurred.
Integrity, however, requires something the system no longer demands.
Integrity requires a person to do the right thing, even when doing so threatens position, funding, or power.
Modern campaign finance offers a convenient alternative.
After Citizens United, the flow of political money no longer needs to change a vote. It only needs to shape the environment around the vote—quietly rewarding those who protect the interests behind it and quietly isolating those who do not.
Inside that environment, the ugliest decisions rarely look corrupt.
They look procedural.
The bill was postponed.
Negotiations continue.
The matter remains under discussion.
Meanwhile, a father sits at a kitchen table studying a pharmacy receipt while his son finishes math homework beside him.
The system did not fail.
It simply revealed that when political survival depends on money, integrity is no longer required for the outcome to look legitimate.
—Mark Bertrand
The Reader’s Court
When systems break people’s lives, the truth must be told.
Join the fight.
0 comments
Write a comment